Reduction of metastatic carcinoma cells in bone marrow by intravenously administered monoclonal antibody: Towards a novel surrogate test to monitor adjuvant therapies of solid tumours
- 31 October 1995
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (11) , 1799-1803
- https://doi.org/10.1016/0959-8049(95)00317-c
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinomaThe Lancet, 1994
- Methodological Analysis of Immunocytochemical Screening for Disseminated Epithelial Tumor Cells in Bone MarrowJournal of Hematotherapy, 1994
- Differential Expression of Proliferation-Associated Molecules in Individual Micrometastatic Carcinoma CellsJNCI Journal of the National Cancer Institute, 1993
- Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patientsThe Lancet, 1992
- Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancersCurrent Opinion in Immunology, 1992
- Micrometastatic tumour cells in bone marrow of patients with gastric cancer: Methodological aspects of detection and prognostic significanceEuropean Journal of Cancer and Clinical Oncology, 1991
- The control of homologous lysisImmunology Today, 1991
- Biological activity in the human system of isotype variants of oligosaccharide-Y-specific murine monoclonal antibodiesCancer Immunology, Immunotherapy, 1991
- Oligosaccharide Y Specific Monoclonal Antibody and Its Isotype Switch VariantsHybridoma, 1990
- Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases.BMJ, 1987